insights_auto
Sebab ALNY menurun 2.71%?
Terokai Dengan Lebih Terperincichevron_right
ALNY:NASDAQ
Alnylam Pharmaceuticals, Inc.
USD 143.82
arrow_downward
-2.71%(-4.00) 1H
USD 144.50
arrow_upward
+0.47% (+0.68)bedtimeSelepas waktu pejabat
Ditutup: 20 Nov, 4:00:00 PTG GMT-5 · USD
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk ALNY...
Buka
USD 148.35
Tinggi
USD 151.40
Rendah
USD 143.40
Permodalan Pasaran
19.26B
Purata volum
2.71J
Volum
2.33J
Nisbah H/P
7.28
tgi 52 mgu
USD 479.79
rdh 52 mgu
USD 143.40
EPS
USD 19.75
Beta
0.42
Syer tertunggak
133.94J
Bilangan pekerja
2K
Buka
USD 148.35
Tinggi
USD 151.40
Rendah
USD 143.40
Permodalan Pasaran
19.26B
Purata volum
2.71J
Volum
2.33J
Nisbah H/P
7.28
tgi 52 mgu
USD 479.79
rdh 52 mgu
USD 143.40
EPS
USD 19.75
Beta
0.42
Syer tertunggak
133.94J
Bilangan pekerja
2K
Cerita berita
Daripada sumber web dan rakan kongsi berita
ChartMill
·
1 jam lalu
Alnylam Pharmaceuticals (NASDAQ:ALNY) Screens as a Balanced Affordable Growth Candidate
GuruFocus
·
20 jam lalu
ALNY Maintained by BMO Capital -- Price Target Raised to $293
Benzinga
·
1 hari lalu
Jim Cramer Rejects UiPath Despite Cheap Valuation, Backs Affirm
Yahoo Finance
·
1 hari lalu
Alnylam Pharmaceuticals (ALNY) Stock Dropped, So What Is Driving Attention Now?
Profil
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
Perihal Alnylam Pharmaceuticals, Inc.